Link to article on Factset Insight: https://insight.factset.com/investors-and-traders-need-to-track-prescription-drug-user-fee-act-pdufa-content
Summary:
PDUFA dates and content are essential for portfolio managers of healthcare stocks. A single positive or negative announcement from the U.S. Food and Drug Administration (FDA) can send shares of a biotech firm soaring or turn a hot name quickly into a bear market.
Related Content
-
Buybacks Reach Record Highs as Q2 Earnings Season Approaches
-
The Great ESG Rebrand: Why a Quieter Approach to Sustainability Is Winning
-
2025’s Box Office Bonanza: Blockbusters, Busts, and a Summer Showdown
-
Tariffs Take a Toll: What to Expect from Interim Auto Reports Next Week
-
Tracking Strong Dividend-Increase Trends Amid Macro Uncertainty
-
M&A Watch: A String of Hot IPOs Could Spark Second-Half Dealmaking
-
Recent Academic Research Shows Which Q2 Earnings Reports Could Have the Biggest Impact on Markets
-
Reverse Splits Start to Moderate After Hitting a Record High in Q1 2025
-
Jobs Week on Wall Street: Hard and Soft Data Go Head-to-Head
-
IPO Filings Remain Low in Q2